Convalescent plasma therapy for COVID-19 – Donor selection strategies and establishment of a plasma bank

Convalescent plasma therapy for COVID-19 – Donor selection strategies and establishment of a plasma bank

Background: Early in the COVID-19 pandemic, convalescent plasma (CP) emerged as a potentially effective treatment neutralising SARS-CoV-2. Early CP therapy with high neutralising antibody (NAb) titre may benefit COVID-19 outpatients and, in sufficient quantities even some hospitalised patients. This...

Full description

Saved in:
Bibliographic Details
Main Authors: Mikael Kajova, Tamim Khawaja, Iris Levonen, Jukka-Pekka Pietilä, Jenni Virtanen, Sari H. Pakkanen, Hanna Välimaa, Arttu Nousiainen, Jussi Hepojoki, Tarja Sironen, Antti Vierikko, Jarkko Ihalainen, Olli Vapalahti, Anu Kantele
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:New Microbes and New Infections
Subjects:
COVID-19
SARS-CoV-2
Convalescent plasma
Plasma bank
Neutralising antibodies
Online Access:http://www.sciencedirect.com/science/article/pii/S2052297524003093
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2052297524003093

Similar Items